Bioterrorism And Gene Editing: Can Crispr Tool Be Used As Biological Weapon In War?
By Himanshu Goenka,
IB Times
| 12. 14. 2016
Crispr is a tool that allows for genes to be edited, and has great potential in the treatment of a wide range of diseases, including some for which there is currently no known cure. It rose to prominence in 2015, when it was chosen as the breakthrough technology of the year by the American Association for the Advancement of Science, and became even better known in 2016 when scientists behind it were strong contenders for the Nobel Prize (which it finally didn’t win) and also appeared in Time magazine’s readers’ poll for the Person of the Year title.
Even as a legal battle is currently underway for the patent rights to Crispr (its Cas9 variant, to be specific), the technology is far from perfect right now — scientists are still working on making it more precise and the first human test involving a gene modified using Crispr took place only in October. And yet, it has made it to the list put together by U.S. intelligence agencies on national security threats.
However, in a somewhat surprising announcement in February 2016...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...
